Sequences

Sample result

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

SIINFEKL, an exact peptide

Exact text → Patent proteins

Download as Excel

Every list and the search record, one sheet each.

Query
SIINFEKL · 8 lettersSIINFEKL
Set
Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
Ran
2026-11-12
Found
771 sequences, 2,028 publications, 1,357 families

Charts

Identity against coverage

771 hits by identity and query coverage. 771 with a date.

Has a date90909292949496969898100100Identity (%)Query coverage (%)
Show table
Hits by identity
BandHas a dateAll
100%771771
Hits by query coverage
BandHas a dateAll
100%771771

Hits by year

1,357 families by year of first publication, 1994 to 2026.

Has a dateFamilies05010015019941997200020032006200920122015201820212024
Show table
Families by year of first publication
YearHas a dateAll
199411
199511
199855
199944
200022
20012323
20021414
20031717
20041515
20053737
20063131
20072929
20082828
20093232
20103232
20114848
20123535
20134646
20144242
20156161
20166969
20177979
20188282
20198686
20208080
20218787
20226666
20239494
2024102102
20258181
20262828

Where hits align on the query

The top 20 hits on SIINFEKL, a query of 8 amino acids: 20 cover the whole query, none differs from it.

Aligned partDiffers from the querySIINFEKL · 8 amino acids12468SIINFEKLAAE13361.1AAA94863.1AAC86077.1AAO94511.1AAO94501.1CS072231.1CS072222.1AZK27020.1CS072221.1ABH87918.1ABH87917.1ABH87919.1AX288232.1AX288234.1AX288233.1AX288231.1AX288237.1AX288235.1AX288236.1AQN09305.1
Show table
The top 20 hits on SIINFEKL, positions on the query
HitQuery fromQuery toIdentityDiffers atGaps atX at
AAE13361.118100.0%NoneNoneNone
AAA94863.118100.0%NoneNoneNone
AAC86077.118100.0%NoneNoneNone
AAO94511.118100.0%NoneNoneNone
AAO94501.118100.0%NoneNoneNone
CS072231.118100.0%NoneNoneNone
CS072222.118100.0%NoneNoneNone
AZK27020.118100.0%NoneNoneNone
CS072221.118100.0%NoneNoneNone
ABH87918.118100.0%NoneNoneNone
ABH87917.118100.0%NoneNoneNone
ABH87919.118100.0%NoneNoneNone
AX288232.118100.0%NoneNoneNone
AX288234.118100.0%NoneNoneNone
AX288233.118100.0%NoneNoneNone
AX288231.118100.0%NoneNoneNone
AX288237.118100.0%NoneNoneNone
AX288235.118100.0%NoneNoneNone
AX288236.118100.0%NoneNoneNone
AQN09305.118100.0%NoneNoneNone

Patents 2K

Columns
Tick the columns each row shows, then choose Show. The arrows move a column.

2,028 publications in 1,357 families match these filters.

  1. INDIVIDUALIZED VACCINES FOR CANCER

    BIONTECH AG

    Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  2. US 8323662-B12012-12-04

    Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein

    Immune Design Corp.

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  3. US 8323696-B22012-12-04

    Nanoparticles for immunotherapy

    Ecole Polytechnique Federale de Lausanne

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  4. US 8329197-B22012-12-11

    Ex vivo uses of immunostimulatory combinations

    3M Innovative Properties Company and Trustees of Dartmouth

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  5. US 8357363-B22013-01-22

    Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom

    Aicuris GmbH & Co. KG

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  6. JP 2013504623-A2013-02-07

    Modulation of Yeast-Based Immunotherapy Products and Responses

    The Regents of the University of Colorado

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  7. EP 2558109-A22013-02-20

    METHOD FOR TREATING SOLID TUMORS

    BELLICUM PHARMACEUTICALS INC

    Family of 3

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, US 61/325127.

  8. 3D8 scFv-T cell epitope fusion protein and vaccine composition comprising the same

    AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

    Best alignment

    Query 1 to 8, hit 8 to 15. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    8 SIINFEKL 15
    

    8 of 8 identical, no gaps.

  9. US 8394385-B22013-03-12

    Optimized early-late promoter combined with repeated vaccination favors cytotoxic T cell response against recombinant antigen in MVA vaccines

    Bavarian Nordic A/S

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  10. US 8394590-B22013-03-12

    Capture agents and related methods and systems for detecting and/or sorting targets

    California Institute of Technology and University of California

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  11. NANOPARTICLE-PEPTIDE COMPOSITIONS

    MIDATECH LTD

    Family of 4

    Best alignment and family

    Query 1 to 8, hit 3 to 10. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    3 SIINFEKL 10
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by the same title and applicant. No priority claim is on record.

  12. NANOPARTICLE TUMOUR VACCINES

    MIDATECH LTD

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 3 to 10. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    3 SIINFEKL 10
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  13. US 8398992-B22013-03-19

    Methods and compositions for polytopic vaccination

    Polytopos LLC

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  14. METHODS OF PROMOTING IMMUNE TOLERANCE

    GEORGIA HEALTH SCIENCES UNIVERSITY

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  15. EP 2576791-A12013-04-10

    METHODS AND COMPOSITIONS USING LISTERIA FOR ADJUVANT TREATMENT OF CANCER

    ADURO BIOTECH

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  16. US 8420078-B22013-04-16

    Methods and immunogenic cell preparations for treating antigen-associated diseases

    Yeda Research and Development Co. Ltd.

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  17. US 8420102-B22013-04-16

    Compositions that include hemagglutinin

    VaxInnate Corporation

    Best alignment

    Query 1 to 8, hit 765 to 772. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   765 SIINFEKL 772
    

    8 of 8 identical, no gaps.

  18. US 8425917-B22013-04-23

    Mutant forms of EtxB and CtxB and their use as carriers

    Best alignment

    Query 1 to 8, hit 12 to 19. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   12 SIINFEKL 19
    

    8 of 8 identical, no gaps.

  19. EP 2589654-A12013-05-08

    CD40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity

    UNIV COLORADO REGENTS

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  20. EP 2593548-A12013-05-22

    HUMAN PAPILLOMAVIRUS E7 ANTIGEN COMPOSITIONS AND USES THEREOF

    BRITISH COLUMBIA CANCER AGENCY

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  21. EP 2598631-A12013-06-05

    RECOMBINANT BACTERIUM AND USES THEREOF

    CANADA NAT RES COUNCIL

    Best alignment

    Query 1 to 8, hit 395 to 402. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   395 SIINFEKL 402
    

    8 of 8 identical, no gaps.

  22. US 8465756-B22013-06-18

    Immunogenic peptides of tumor associated antigen L6 and uses thereof in cancer therapy

    National Health Research Institutes

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  23. EP 2603520-A22013-06-19

    ERYTHROCYTE-BINDING THERAPEUTICS

    ECOLE POLYTECH

    Best alignment

    Query 1 to 8, hit 8 to 15. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    8 SIINFEKL 15
    

    8 of 8 identical, no gaps.

  24. JP 2013527758-A2013-07-04

    Vaccine against beta-herpesvirus infection and use thereof

    Christian Thirion,Ulrich Koszinowski,Christian A Mohr,Zsolt Ruzsics

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 259 to 266. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   259 SIINFEKL 266
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by a shared priority claim, EP 10004751.3.

  25. EP 2612149-A22013-07-10

    COMPOSITIONS AND METHODS FOR DIAGNOSING AND MONITORING DISEASE AND TREATMENT VIA ANTIGEN-SPECIFIC MOLECULES

    PHARMASAN LABS INC

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  26. METHOD FOR PRODUCING AN EXAMINATION REAGENT AND KIT FOR ANALYSING A T-CELL FREQUENCY

    UNIV JACOBS BREMEN GMBH

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  27. US 8486693-B22013-07-16

    Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods

    Bellicum Pharmaceuticals, Inc.

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  28. DUAL ANTIGEN-INDUCED BIPARTITE FUNCTIONAL COMPLEMENTATION

    UNIV WUERZBURG J MAXIMILIANS

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  29. EP 2616545-A12013-07-24

    COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA

    UNIV PITTSBURGH

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  30. EP 2619229-A22013-07-31

    MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

    ALTOR BIOSCIENCE CORP

    Family of 12

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 12

    Grouped by the same title and applicant. No priority claim is on record.

  31. EP 2623121-A12013-08-07

    Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen

    BAYER INNOVATION GMBH

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  32. PHARMACEUTICAL COMPOSITION COMPRISING A POLYMERIC CARRIER CARGO COMPLEX AND AT LEAST ONE PROTEIN OR PEPTIDE ANTIGEN

    CUREVAC GMBH

    Family of 3

    Best alignment and family

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by the same title and applicant. No priority claim is on record.

  33. PHARMACEUTICAL COMPOSITION COMPRISING A POLYMERIC CARRIER CARGO COMPLEX AND AT LEAST ONE PROTEIN OR PEPIDE ANTIGEN

    CUREVAC GMBH

    Best alignment

    Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   258 SIINFEKL 265
    

    8 of 8 identical, no gaps.

  34. NEGATIVELY CHARGED NUCLEIC ACID COMPRISING COMPLEXES FOR IMMUNOSTIMULATION

    CUREVAC GMBH

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  35. US 8518697-B22013-08-27

    Single chain trimers and uses therefor

    Washington University

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  36. US 8530153-B12013-09-10

    Lentiviral transduced dendritic cells for RNAi

    Technologiy Transfer Office, University of Manitoba

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  37. US 8540965-B22013-09-24

    Single wall nanotube constructs and uses therefor

    Sloan-Kettering Institute for Cancer Research

    Best alignment

    Query 1 to 8, hit 5 to 12. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    5 SIINFEKL 12
    

    8 of 8 identical, no gaps.

  38. US 8541544-B22013-09-24

    Molecular marker for cancer stem cell

    Dainippon Sumitomo Pharma Co., Ltd. and Sapporo Medical University

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  39. EP 2640751-A12013-09-25

    LIPIDATED POLYEPITOPE VACCINES

    NAT HEALTH RESEARCH INSTITUTES

    Best alignment

    Query 1 to 8, hit 74 to 81. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit   74 SIINFEKL 81
    

    8 of 8 identical, no gaps.

  40. LENTIVIRAL VECTOR PARTICLES HAVING IMPROVED TRANSDUCTION EFFICIENCY FOR CELLS EXPRESSING DC- SIGN

    IMMUNE DESIGN CORP

    Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, US 61/666103.

  41. US 8562988-B22013-10-22

    Strategies for improved cancer vaccines

    IBC Pharmaceuticals, Inc.

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  42. US 8574588-B22013-11-05

    Fusion proteins comprising flagellin and dengue viral envelope proteins

    VanInnate Corporation

    Best alignment

    Query 1 to 8, hit 765 to 772. Positions start at 1 and include both ends.

    Query   1 SIINFEKL 8
              ||||||||
    Hit   765 SIINFEKL 772
    

    8 of 8 identical, no gaps.

  43. JP 2013540421-A2013-11-07

    HUMAN PAPILLOMAVIRUS E7 ANTIGEN COMPOSITIONS AND USES THEREOF

    BRITISH COLUMBIA CANCER AGENCY BRANCH

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  44. US 8580269-B22013-11-12

    Survivin peptides for autoimmune therapies

    Health Research, Inc.

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  45. JP 2013541335-A2013-11-14

    MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

    ALTOR BIOSCIENCE CORPORATION

    Family of 4

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 4

    Grouped by a shared priority claim, US 61/384817.

  46. JP 2013541504-A2013-11-14

    ERYTHROCYTE-BINDING THERAPEUTICS

    Ecole Polytechnique Federale de Lausanne

    Family of 3

    Best alignment and family

    Query 1 to 8, hit 8 to 15. Positions start at 1 and include both ends.

    Query  1 SIINFEKL 8
             ||||||||
    Hit    8 SIINFEKL 15
    

    8 of 8 identical, no gaps.

    Family of 3

    Grouped by a shared priority claim, US 61/372181.

  47. US 8597664-B22013-12-03

    Endogenous adjuvant molecules and uses thereof

    University of Massachusetts

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  48. JP 2013543506-A2013-12-05

    METHODS AND COMPOSITIONS FOR INDUCING A T-CELL RESPONSE TO PLASMODIUM SPECIES

    ADURO BIOTECH INC

    Best alignment

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

  49. US 8613936-B22013-12-24

    Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements

    Bavarian Nordic A/S

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.

  50. POXVIRAL VECTORS FOR LOW ANTIBODY RESPONSE AFTER A FIRST PRIMING IMMUNIZATION

    BAVARIAN NORDIC AS

    Family of 2

    Best alignment and family

    Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.

    Query 1 SIINFEKL 8
            ||||||||
    Hit   1 SIINFEKL 8
    

    8 of 8 identical, no gaps.

    Family of 2

    Grouped by the same title and applicant. No priority claim is on record.